Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.71 |
| ▸ | FNTB | P49356 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | MCL1 | Q07820 | 13/20 | 0.58 |
| ▸ | BCL2L1 | Q07817 | 6/20 | 0.58 |
| ▸ | BCL2 | P10415 | 9/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | BID | P55957 | 1/20 | 0.45 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17294107 | 1.00 | FNTA (0.71) | FNTAALDH1A1PKMPGGT1BFNTB | |
| SCHEMBL13976672 | 0.92 | FNTA (0.75) | FNTAALDH1A1PKMPGGT1BFNTB | |
| SCHEMBL17295368 | 0.92 | FNTA (0.75) | FNTAALDH1A1PKMPGGT1BFNTB | |
| SCHEMBL17295471 | 0.92 | FNTA (0.75) | FNTAALDH1A1PKMPGGT1BFNTB | |
| SCHEMBL13976673 | 0.92 | FNTA (0.75) | FNTAALDH1A1PKMPGGT1BFNTB | |
| SCHEMBL11627085 | 0.83 | FNTA (1.00) | FNTAALDH1A1PKMPGGT1BFNTB | |
| SCHEMBL11133830 | 0.80 | FNTA (0.61) | FNTAALDH1A1PKMPGGT1BFNTB | |
| SCHEMBL24362208 | 0.79 | FNTA (0.60) | FNTAALDH1A1PKMPGGT1BFNTB | |
| SCHEMBL13976267 | 0.78 | FNTA (0.72) | FNTAALDH1A1PKMPGGT1BFNTB | |
| SCHEMBL15932845 | 0.77 | FNTA (0.65) | FNTAALDH1A1PKMPGGT1BFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10227281-B2 | Preparation of 2,6- and 2,7-disubstituted anthraquinone derivates | BASF SE (DE) | 2019-03-12 | — | — | US | disclosed |
| US-20180215694-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATES | BASF SE (DE) | 2018-08-02 | — | — | US | disclosed |
| US-9988268-B2 | Preparation of 2,6- and 2,7-disubstituted anthraquinone derivatives | BASF SE (DE) | 2018-06-05 | — | — | US | disclosed |
| US-9988268-B2 | Preparation of 2,6- and 2,7-disubstituted anthraquinone derivatives | BASF SE (DE) | 2018-06-05 | — | — | US | disclosed |
| US-9988268-B2 | Preparation of 2,6- and 2,7-disubstituted anthraquinone derivatives | BASF SE (DE) | 2018-06-05 | — | — | US | disclosed |
| EP-3148928-B1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | BASF SE (DE) | 2018-02-28 | — | — | EP | disclosed |
| EP-3148928-B1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | BASF SE (DE) | 2018-02-28 | — | — | EP | disclosed |
| EP-3148927-B1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATES | BASF SE (DE) | 2018-02-28 | — | — | EP | disclosed |
| US-20170197830-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | BASF SE (DE) | 2017-07-13 | — | — | US | disclosed |
| US-20170197830-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | BASF SE (DE) | 2017-07-13 | — | — | US | disclosed |
| US-20170197830-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | BASF SE (DE) | 2017-07-13 | — | — | US | disclosed |
| EP-3148928-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | BASF SE (DE) | 2017-04-05 | — | — | EP | disclosed |
| EP-3148927-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATES | BASF SE (DE) | 2017-04-05 | — | — | EP | disclosed |
| WO-2015181297-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | BASF SE (DE) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015181297-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | BASF SE (DE) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015181283-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATES | BASF SE (DE) | 2015-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170197830-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | ANTXR2, NQO1, DHPS | FNTA 2228/4885ALDH1A1 458/4885PKM 3040/4885 |
| US-20180215694-A1 | PREPARATION OF 2,6- AND 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATES | NQO1, CYP1B1, SDHA | FNTA 655/4885ALDH1A1 162/4885PKM 971/4885 |
| US-10227281-B2 | Preparation of 2,6- and 2,7-disubstituted anthraquinone derivates | NQO1, CYP1B1, SDHA | FNTA 655/4885ALDH1A1 162/4885PKM 971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.